Rare diseases
Investigational molecules
Locations
Study of Dostarlimab After Chemoradiation for Adults with Advanced Unresected Head and Neck Cancer
SpainStudy on Long-Term Safety of Ianalumab for Patients with Systemic Lupus Erythematosus
SpainStudy on Long-term Safety of Nivolumab and Drug Combination for Cancer Patients from Previous BMS Trials
SpainStudy of Tucatinib, Trastuzumab, and mFOLFOX6 for Patients with HER2+ Metastatic Colorectal Cancer
SpainStudy on RVU120 and Venetoclax for Patients with Acute Myeloid Leukemia After Previous Treatment Failure
SpainStudy on the Long-term Safety and Efficacy of Pembrolizumab and Lenvatinib for Patients with Advanced Tumors
SpainStudy on Vafidemstat for Treating Negative Symptoms and Cognitive Impairment in Adults with Schizophrenia
SpainA Study of Setidegrasib with Chemotherapy Drug Combination as First‑Line Treatment in Adults with KRAS G12D‑mutated Metastatic Pancreatic Cancer
SpainStudy of LY3537982, pembrolizumab, and a drug combination for patients with advanced non-small cell lung cancer and a KRAS G12C mutation
SpainPhase 3 Extension Trial Evaluating Long‑Term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity
SpainRinatabart Sesutecan with or without bevacizumab versus standard platinum‑based chemotherapy drug combination in patients with recurrent platinum‑sensitive ovarian cancer
SpainRamantamig (JNJ-79635322) with drug combination versus standard therapy in newly diagnosed multiple myeloma patients not eligible for stem cell transplant
SpainTell us about your condition – we search every trial in Europe and connect you with the right site.
